• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌在不吸烟患者与吸烟患者中的临床表现差异。

Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

机构信息

Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Korea;

Division of Hematology-Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Korea;

出版信息

J Thorac Dis. 2013 Dec;5(6):758-63. doi: 10.3978/j.issn.2072-1439.2013.11.24.

DOI:10.3978/j.issn.2072-1439.2013.11.24
PMID:24409352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3886698/
Abstract

OBJECTIVES

This study was conducted to evaluate whether or not tumor spread and the diagnostic process in non-small cell lung cancer (NSCLC) is different based on smoking history.

METHODS

Associations between smoking status and clinical presentation were evaluated controlling for the effect of histology. Lung cancer with delayed diagnosis (LCDD) and incidental detection (LCID) were determined based on medical records.

RESULTS

Of 914 patients, frequency of distant metastases was more common in never-smokers than in smokers (59% and 36%, respectively; P<0.001). Although never-smokers were more likely to have LCDD than smokers (18% and 11%, respectively; P=0.038), LCDD were not significantly associated with frequency of distant metastases [49% (LCDD) vs. 42% (non-LCDD); P=0.189] as well as tumor [29% (T3-4) vs. 24% (T1-2); P=0.134] and node [43% (N2-3) vs. 44% (N0-1); P=0.838] stage. Interestingly, never-smokers are more likely to have LCID than smokers (31% and 19%, respectively; P=0.010). In survival analysis, LCID (P=0.001; HR, 0.63) remained a prognostic factor, while LCDD did not.

CONCLUSIONS

This study suggests distinct metastatic pattern and diagnostic processes of never-smokers. The link between survival and incidental detection was also indicated.

摘要

目的

本研究旨在评估非小细胞肺癌(NSCLC)的肿瘤转移和诊断过程是否因吸烟史而不同。

方法

通过控制组织学的影响,评估吸烟状况与临床表现之间的关联。根据病历确定肺癌延迟诊断(LCDD)和偶然发现(LCID)。

结果

在 914 名患者中,从不吸烟者远处转移的频率高于吸烟者(分别为 59%和 36%;P<0.001)。尽管从不吸烟者比吸烟者更有可能出现 LCDD(分别为 18%和 11%;P=0.038),但 LCDD 与远处转移的频率(49%(LCDD)与 42%(非-LCDD);P=0.189)以及肿瘤(29%(T3-4)与 24%(T1-2);P=0.134)和淋巴结(43%(N2-3)与 44%(N0-1);P=0.838)分期均无显著相关性。有趣的是,从不吸烟者比吸烟者更有可能出现 LCID(分别为 31%和 19%;P=0.010)。在生存分析中,LCID(P=0.001;HR,0.63)仍然是一个预后因素,而 LCDD 则不是。

结论

本研究表明,从不吸烟者具有独特的转移模式和诊断过程。生存与偶然发现之间的联系也得到了证实。

相似文献

1
Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.非小细胞肺癌在不吸烟患者与吸烟患者中的临床表现差异。
J Thorac Dis. 2013 Dec;5(6):758-63. doi: 10.3978/j.issn.2072-1439.2013.11.24.
2
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.患非小细胞肺癌的吸烟者与从不吸烟者在流行病学、组织学和生存率方面的差异。
Chest. 2007 Jul;132(1):185-92. doi: 10.1378/chest.07-0442. Epub 2007 Jun 15.
3
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).非小细胞肺癌(NSCLC)终身不吸烟者的临床表现及特定分期结局。
J Thorac Oncol. 2007 Sep;2(9):827-30. doi: 10.1097/JTO.0b013e318145af79.
4
Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.非小细胞肺癌手术和非手术患者的吸烟状况与长期生存结果:从不吸烟者和现吸烟者比较。
Chest. 2010 Sep;138(3):500-9. doi: 10.1378/chest.08-2991. Epub 2010 May 27.
5
Impact of smoking on mortality of patients with non-small cell lung cancer.吸烟对非小细胞肺癌患者死亡率的影响。
Thorac Cancer. 2014 Jan;5(1):43-9. doi: 10.1111/1759-7714.12051. Epub 2014 Jan 2.
6
Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.性别、组织学和诊断时间是预后的重要因素:对日本 1499 例晚期非小细胞肺癌从不吸烟患者的分析。
J Thorac Oncol. 2010 Jul;5(7):1011-7. doi: 10.1097/JTO.0b013e3181dc213e.
7
Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.手术切除的 N2 期非小细胞肺癌中跳跃性转移的生存获益:一项对中国患者大队列进行的多中心观察性研究。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1874-1881. doi: 10.1016/j.ejso.2019.12.015. Epub 2019 Dec 18.
8
Proportion and clinical features of never-smokers with non-small cell lung cancer.非小细胞肺癌不吸烟者的比例及临床特征
Chin J Cancer. 2017 Feb 8;36(1):20. doi: 10.1186/s40880-017-0187-6.
9
Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.不吸烟人群中的非小细胞肺癌作为一种代表性的“非吸烟相关肺癌”:流行病学和临床特征。
Int J Clin Oncol. 2011 Aug;16(4):287-93. doi: 10.1007/s10147-010-0160-8. Epub 2011 May 13.
10
Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.癌症护理结果研究与监测(CanCORS)中肺癌非吸烟者的生存率
Ann Am Thorac Soc. 2016 Jan;13(1):58-66. doi: 10.1513/AnnalsATS.201504-241OC.

引用本文的文献

1
Lung cancer in never smokers (LCINS): development of a UK national research strategy.从不吸烟者的肺癌(LCINS):英国国家研究战略的制定
BJC Rep. 2023 Jul 20;1(1):21. doi: 10.1038/s44276-023-00006-w.
2
Unusual presentation of rearranged metastatic non-small cell lung cancer.重排转移性非小细胞肺癌的不寻常表现。
Respir Med Case Rep. 2024 Aug 18;51:102091. doi: 10.1016/j.rmcr.2024.102091. eCollection 2024.
3
Sociodemographic and clinical characteristics associated with never-smoking status in patients with lung cancer: findings from a large integrated health system.肺癌患者中与从不吸烟状态相关的社会人口学和临床特征:来自大型综合医疗系统的研究结果
Transl Cancer Res. 2022 Oct;11(10):3522-3534. doi: 10.21037/tcr-22-1438.
4
Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.中国东部地区 cT1 期肺癌淋巴结转移术前风险评估的回顾性研究。
J Immunol Res. 2019 Dec 1;2019:6263249. doi: 10.1155/2019/6263249. eCollection 2019.
5
Early screening of lung cancers: an effort arduous but worthwhile.肺癌的早期筛查:一项艰巨但值得的工作。
Chin J Cancer Res. 2015 Dec;27(6):617-8. doi: 10.3978/j.issn.1000-9604.2015.12.04.

本文引用的文献

1
Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: implications for intervention.烟草成分和心理压力对非小细胞肺癌和胰腺癌β-肾上腺素能调控的影响:干预意义。
Cancer Biomark. 2013;13(3):133-44. doi: 10.3233/CBM-130323.
2
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.表皮生长因子受体酪氨酸激酶抑制剂治疗表皮生长因子受体突变型非小细胞肺癌脑转移。
Clin Cancer Res. 2012 Feb 15;18(4):938-44. doi: 10.1158/1078-0432.CCR-11-2529. Epub 2011 Dec 13.
3
Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer.表皮生长因子受体突变与非小细胞肺癌转移表现的相关性
ISRN Oncol. 2011;2011:756265. doi: 10.5402/2011/756265. Epub 2011 Apr 27.
4
Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer.社会压力促进和γ-氨基丁酸抑制非小细胞肺癌小鼠模型中的肿瘤生长。
Cancer Prev Res (Phila). 2012 Feb;5(2):189-96. doi: 10.1158/1940-6207.CAPR-11-0177. Epub 2011 Sep 28.
5
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
6
Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.不同组织学分型肺癌 CT 筛查效果的差异:日本吸烟者低剂量 CT 筛查检出病例分析。
Lung Cancer. 2011 Dec;74(3):433-40. doi: 10.1016/j.lungcan.2011.05.007. Epub 2011 Jun 12.
7
Overview of the National Cancer screening programme and the cancer screening status in Korea.韩国国家癌症筛查计划及癌症筛查现状概述。
Asian Pac J Cancer Prev. 2011;12(3):725-30.
8
Early detection and screening of lung cancer.肺癌的早期发现和筛查。
Expert Rev Mol Diagn. 2010 Sep;10(6):799-815. doi: 10.1586/erm.10.60.
9
Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era.与白种人相比,在口服表皮生长因子受体酪氨酸激酶抑制剂时代之前和之后,韩国人种是非小细胞肺癌总生存的独立有利预后因素。
J Thorac Oncol. 2010 Aug;5(8):1185-96. doi: 10.1097/JTO.0b013e3181e2f624.
10
Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study.基于电子健康记录的肺癌诊断中错失机会的特征和预测因素研究。
J Clin Oncol. 2010 Jul 10;28(20):3307-15. doi: 10.1200/JCO.2009.25.6636. Epub 2010 Jun 7.